RxDoctor Payments Data

Stephanie Farmer

Nurse Practitioner · Paris, TNNPI 1285808097

Payments from drug & device makers

$2,617in general payments, 2019–2025

Across 110 payments — averaging $23.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$377
  • AbbVie$372
  • Novo Nordisk$349
  • Takeda Pharmaceuticals U.S.A., Inc.$287
  • Amgen$256
  • Boehringer Ingelheim$100
  • plus $877 from 23 others

What the payments were for

  • Food & beverage$2,57298%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,617 in reported general payments places this provider in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide27$35,442
EliquisApixaban17$17,514
OzempicSemaglutide18$16,315
JardianceEmpagliflozin11$7,612
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,804
SynthroidLevothyroxine Sodium16$1,451
Fenofibrate36$1,417
Albuterol Sulfate HfaAlbuterol Sulfate25$1,237
Omeprazole94$1,173
Atorvastatin Calcium70$958
Fluticasone Propionate55$951
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide16$861
Dicyclomine Hcl22$785
Rosuvastatin Calcium63$769
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst41$674

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$377$35,44227 claims
PfizerEliquis$50$17,51417 claims
Novo NordiskOzempic$349$16,31518 claims
Boehringer IngelheimJardiance$100$7,61211 claims
GSKTrelegy Ellipta$15$6,80411 claims
AbbVieSynthroid$372$1,45116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Paris

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →